RBC Capital lowered the firm’s price target on Andlauer Healthcare to C$41 from C$43 and keeps a Sector Perform rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANDHF: